These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 10581502)

  • 1. MR imaging of tumor microcirculation: promise for the new millennium.
    Taylor JS; Tofts PS; Port R; Evelhoch JL; Knopp M; Reddick WE; Runge VM; Mayr N
    J Magn Reson Imaging; 1999 Dec; 10(6):903-7. PubMed ID: 10581502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technical innovation in dynamic contrast-enhanced magnetic resonance imaging of musculoskeletal tumors: an MR angiographic sequence using a sparse k-space sampling strategy.
    Fayad LM; Mugera C; Soldatos T; Flammang A; del Grande F
    Skeletal Radiol; 2013 Jul; 42(7):993-1000. PubMed ID: 23558650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
    Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
    Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
    Rosen MA; Schnall MD
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
    Toms AP; White LM; Kandel R; Bleakney RR; Noseworthy M; Lee S; Blackstein ME; Wunder J
    Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multilevel analysis of spatiotemporal association features for differentiation of tumor enhancement patterns in breast DCE-MRI.
    Lee SH; Kim JH; Cho N; Park JS; Yang Z; Jung YS; Moon WK
    Med Phys; 2010 Aug; 37(8):3940-56. PubMed ID: 20879557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized time-resolved imaging of contrast kinetics (TRICKS) in dynamic contrast-enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models.
    Haeck J; Bol K; Bison S; van Tiel S; Koelewijn S; de Jong M; Veenland J; Bernsen M
    Contrast Media Mol Imaging; 2015; 10(6):413-20. PubMed ID: 25995102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced MRI for oncology drug development.
    Sung YS; Park B; Choi Y; Lim HS; Woo DC; Kim KW; Kim JK
    J Magn Reson Imaging; 2016 Aug; 44(2):251-64. PubMed ID: 26854494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images.
    Egeland TA; Simonsen TG; Gaustad JV; Gulliksrud K; Ellingsen C; Rofstad EK
    Radiat Res; 2009 Sep; 172(3):339-47. PubMed ID: 19708783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.
    Choyke PL; Dwyer AJ; Knopp MV
    J Magn Reson Imaging; 2003 May; 17(5):509-20. PubMed ID: 12720260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast agents in dynamic contrast-enhanced magnetic resonance imaging.
    Yan Y; Sun X; Shen B
    Oncotarget; 2017 Jun; 8(26):43491-43505. PubMed ID: 28415647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New opportunities, MRI biomarkers in the evaluation of head and neck cancer].
    Gődény M; Léránt G
    Magy Onkol; 2014 Dec; 58(4):269-80. PubMed ID: 25517445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.
    Kim J; Kim E; Euceda LR; Meyer DE; Langseth K; Bathen TF; Moestue SA; Huuse EM
    J Magn Reson Imaging; 2018 Jun; 47(6):1589-1600. PubMed ID: 29205621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
    Wu J; Gong G; Cui Y; Li R
    J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators.
    Pickles MD; Lowry M; Manton DJ; Turnbull LW
    Eur Radiol; 2015 Apr; 25(4):1097-106. PubMed ID: 25424563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for pharmacokinetic modelling of dynamic contrast enhanced MRI studies of rapidly enhancing lesions acquired in a clinical setting.
    Radjenovic A; Ridgway JP; Smith MA
    Phys Med Biol; 2006 May; 51(9):N187-97. PubMed ID: 16625029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of antiangiogenic and antivascular drug activity by kinetic analysis of DCE-MRI data.
    Ferl GZ; Port RE
    Clin Pharmacol Ther; 2012 Jul; 92(1):118-24. PubMed ID: 22588603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
    Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
    Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.